The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
Rooshenas L. et al, (2019), Journal of Clinical Epidemiology, 106, 108 - 120
WALKER A., (2019), New England Journal of Medicine
Optimisation of Perioperative Cardiovascular Management to Improve Surgical Outcome II (OPTIMISE II) trial: study protocol for a multicentre international trial of cardiac output-guided fluid therapy with low-dose inotrope infusion compared with usual care in patients undergoing major elective gastrointestinal surgery.
Edwards MR. et al, (2019), BMJ Open, 9
Identifying English Practices that Are High Antibiotic Prescribers Accounting for Comorbidities and Other Legitimate Medical Reasons for Variation
Hope EC. et al, (2018), EClinicalMedicine, 6, 36 - 41
Becchetti L. et al, (2018), Social Choice and Welfare, 51, 595 - 619
Measuring the Economic Value of Sequencing: Why is it Important, Why is it Challenging, and What are Solutions
Phillips KA. et al, (2018), JOURNAL OF MOLECULAR DIAGNOSTICS, 20, 903 - 903
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
Kreimeier S. et al, (2018), Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 21, 1291 - 1298
Written communications from hospital diabetes departments: standards required to mitigate unintentional harm
MC MORROW L. et al, (2018), Diabetic Medicine
Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: the role of rectal artesunate.
Castellani J. et al, (2018), Malar J, 17
Ganesh A. et al, (2018), Neurology
Correction to: multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
Rombach I. et al, (2018), BMC Med Res Methodol, 18
BUCHANAN JR. and WORDSWORTH S., (2018), PharmacoEconomics - Open
Comparison of medical resources, costs, and health utilities among patients with CHD and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation Trial (ACE)
Mc Morrow L. et al, (2018), DIABETOLOGIA, 61, S344 - S344
Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL
Reed SD. et al, (2018), DIABETOLOGIA, 61, S426 - S426
Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial
Becker F. et al, (2018), DIABETOLOGIA, 61, S366 - S366
Ganesh A. et al, (2018), Stroke, 49, 2430 - 2436